BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17661030)

  • 1. The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children.
    Ribeiro MJ; Boddaert N; Bellanné-Chantelot C; Bourgeois S; Valayannopoulos V; Delzescaux T; Jaubert F; Nihoul-Fékété C; Brunelle F; De Lonlay P
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2120-8. PubMed ID: 17661030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA.
    Ribeiro MJ; De Lonlay P; Delzescaux T; Boddaert N; Jaubert F; Bourgeois S; Dollé F; Nihoul-Fékété C; Syrota A; Brunelle F
    J Nucl Med; 2005 Apr; 46(4):560-6. PubMed ID: 15809476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism.
    Capito C; Khen-Dunlop N; Ribeiro MJ; Brunelle F; Aigrain Y; Crétolle C; Jaubert F; De Lonlay P; Nihoul-Fékété C
    Radiology; 2009 Oct; 253(1):216-22. PubMed ID: 19709999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy.
    Zani A; Nah SA; Ron O; Totonelli G; Ismail D; Smith VV; Ashworth M; Blankenstein O; Mohnike W; De Coppi P; Eaton S; Hussain K; Pierro A
    J Pediatr Surg; 2011 Jan; 46(1):204-8. PubMed ID: 21238668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective.
    Meintjes M; Endozo R; Dickson J; Erlandsson K; Hussain K; Townsend C; Menezes L; Bomanji J
    Nucl Med Commun; 2013 Jun; 34(6):601-8. PubMed ID: 23571817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion.
    de Lonlay P; Simon-Carre A; Ribeiro MJ; Boddaert N; Giurgea I; Laborde K; Bellanné-Chantelot C; Verkarre V; Polak M; Rahier J; Syrota A; Seidenwurm D; Nihoul-Fékété C; Robert JJ; Brunelle F; Jaubert F
    J Clin Endocrinol Metab; 2006 Mar; 91(3):933-40. PubMed ID: 16403819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan.
    Hardy OT; Hernandez-Pampaloni M; Saffer JR; Suchi M; Ruchelli E; Zhuang H; Ganguly A; Freifelder R; Adzick NS; Alavi A; Stanley CA
    J Pediatr; 2007 Feb; 150(2):140-5. PubMed ID: 17236890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
    Hardy OT; Hernandez-Pampaloni M; Saffer JR; Scheuermann JS; Ernst LM; Freifelder R; Zhuang H; MacMullen C; Becker S; Adzick NS; Divgi C; Alavi A; Stanley CA
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4706-11. PubMed ID: 17895314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of
    Chroustova D; Trnka J; Pudlac A; Obermannova B; Lambert L
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):279-283. PubMed ID: 32448747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional imaging of the pancreas: the role of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy.
    Ribeiro MJ; Boddaert N; Delzescaux T; Valayannopoulos V; Bellanné-Chantelot C; Jaubert F; Verkarre V; Nihoul-Fékété C; Brunelle F; Lonlay P
    Endocr Dev; 2007; 12():55-66. PubMed ID: 17923769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]Fluoro-L-dopa PET/CT in congenital hyperinsulinism.
    Subramaniam RM; Karantanis D; Peller PJ
    J Comput Assist Tomogr; 2007; 31(5):770-2. PubMed ID: 17895790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiological innovations in the screening and diagnosis of the inborn errors of metabolism].
    Boddaert N; Ribeiro M; Touati G; Mention K; Valayanopoulos V; Nihoul-Fékété C; Brunelle F; de Lonlay P
    Med Sci (Paris); 2005 Nov; 21(11):981-6. PubMed ID: 16274650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism.
    Barthlen W; Blankenstein O; Mau H; Koch M; Höhne C; Mohnike W; Eberhard T; Fuechtner F; Lorenz-Depiereux B; Mohnike K
    J Clin Endocrinol Metab; 2008 Mar; 93(3):869-75. PubMed ID: 18073294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual interpretation, not SUV ratios, is the ideal method to interpret 18F-DOPA PET scans to aid in the cure of patients with focal congenital hyperinsulinism.
    Garg PK; Putegnat B; Truong L; Reynolds C; Sanchez I; Nedrelow JK; Uffman J; Lokitz SJ; Nazih R; Garg S; Thornton PS
    PLoS One; 2020; 15(10):e0241243. PubMed ID: 33108363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation.
    Christiansen CD; Petersen H; Nielsen AL; Detlefsen S; Brusgaard K; Rasmussen L; Melikyan M; Ekström K; Globa E; Rasmussen AH; Hovendal C; Christesen HT
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):250-261. PubMed ID: 29116340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of [¹⁸F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan.
    Masue M; Nishibori H; Fukuyama S; Yoshizawa A; Okamoto S; Doi R; Uemoto S; Tokumi T; Kasai T; Yorifuji T
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):342-6. PubMed ID: 21521340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Feasibility of domestic (18)F-DOPA PET/CT scanning in the differential diagnosis of pancreatic lesions in children with hyperinsulinemic hypoglycemia].
    Zhang MY; Ge JJ; Pei Z; Dong KR; Chen L; Wang X; Zhang ZW; Li XJ; Xi L; Cheng RQ; Lu GP; Guan YH; Luo FH
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):785-789. PubMed ID: 29050119
    [No Abstract]   [Full Text] [Related]  

  • 18. 18F-DOPA positron emission tomography/computed tomography application in congenital hyperinsulinism.
    Yang J; Yuan L; Meeks JK; Zhang N; Li C; Hao R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):619-22. PubMed ID: 23155683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 18F-DOPA PET/CT imaging in congenital hyperinsulinism.
    Ismail D; Hussain K
    Rev Endocr Metab Disord; 2010 Sep; 11(3):165-9. PubMed ID: 20878481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of giant focal forms of congenital hyperinsulinism with incorrect visualization by (18) F DOPA-PET/CT scanning.
    Kühnen P; Matthae R; Arya V; Hauptmann K; Rothe K; Wächter S; Singer M; Mohnike W; Eberhard T; Raile K; Lauffer LM; Iakoubov R; Hussain K; Blankenstein O
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):847-54. PubMed ID: 24750227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.